J Korean Soc Radiol.  2011 Aug;65(2):139-142. 10.3348/jksr.2011.65.2.139.

Acute Abdominal Mobile Aortic Thrombus Post Chemotherapy: Two Cases Reports

Affiliations
  • 1Department of Radiology, Inha University School of Medicine, Incheon, Korea. radjeon@inha.ac.kr

Abstract

An acute abdominal mobile aortic thrombus is a very unusual finding, and this is a potential source of arterial embolism. Mobile aortic thrombus mostly occurs in a diffuse atherosclerotic and aneurysmal aorta. Chemotherapy agents have been documented as a possible rare cause of acute arterial thrombus. We report acute abdominal mobile aortic thrombus post-chemotherapy for pancreatic and stomach cancer.


MeSH Terms

Aneurysm
Angiography
Aorta
Embolism
Stomach Neoplasms
Thrombosis

Figure

  • Fig. 1 A 55-year-old male with abdominal aortic thrombosis after chemotherapy. A. Abdominal CT shows infrarenal intraluminal abdominal aortic thrombus (arrow). B. Fourteen days before chemotherapy, abdominal CT shows no thrombus (arrow). C. One month after thrombolysis, abdominal CT shows disappeared previous infrarenal thrombus (arrow).

  • Fig. 2 A 44-year-old female with abdominal aortic thrombosis after chemotherapy. A. Abdominal CT shows intraluminal aortic thrombus with right renal infarction (arrow). B. Seven days before chemotherapy, abdominal CT shows no thrombus (arrow).

  • Fig. 3 A. Angiogram shows occlude balloon in left renal artery (left upper black arrow) and left iliac artery (left lower black arrow). Abdominal aortic thrombus is noted by intraluminal filling defect (right black arrow). B. A wire-directed balloon catheter thrombectomy was performed using a 27 mm Equalizer balloon catheter (arrow). C. After balloon catheter thrombectomy, angiogram shows successful removal of the aortic thrombus (arrow).

  • Fig. 4 Seven days after chemotherapy, abdominal CT shows disappeared thrombus and slightly recannalization of right renal artery.


Reference

1. Laperche T, Laurian C, Roudaut R, Steg PG. Mobile thromboses of the aortic arch without aortic debris. A transesophageal echocardiographic finding associated with unexplained arterial embolism. The Filiale Echocardiographie de la Société Française de Cardiologie. Circulation. 1997; 96:288–294.
2. Cool RM, Herrington JD, Wong L. Recurrent peripheral arterial thrombosis induced by cisplatin and etoposide. Pharmacotherapy. 2002; 22:1200–1204.
3. Tunick PA, Lackner H, Katz ES, Culliford AT, Giangola G, Kronzon I. Multiple emboli from a large aortic arch thrombus in a patient with thrombotic diathesis. Am Heart J. 1992; 124:239–241.
4. Poirée S, Monnier-Cholley L, Tubiana JM, Arrivé L. Acute abdominal aortic thrombosis in cancer patients. Abdom Imaging. 2004; 29:511–513.
5. Kalangos A, Baldovinos A, Vuille C, Montessuit M, Faidutti B. Floating thrombus in the ascending aorta: a rare cause of peripheral emboli. J Vasc Surg. 1997; 26:150–154.
6. Choukroun EM, Labrousse LM, Madonna FP, Deville C. Mobile thrombus of the thoracic aorta: diagnosis and treatment in 9 cases. Ann Vasc Surg. 2002; 16:714–722.
7. Zhang WW, Abou-Zamzam AM, Hashisho M, Killeen JD, Bianchi C, Teruya TH. Staged endovascular stent grafts for concurrent mobile/ulcerated thrombi of thoracic and abdominal aorta causing recurrent spontaneous distal embolization. J Vasc Surg. 2008; 47:193–196.
8. Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology. 1985; 42:296–300.
9. Barceló R, López-Vivanco G, Mañé JM, Rubio I, Muñoz A, Fernández R. Distal ischemic changes related to combination chemotherapy with cisplatin and gemcitabine: description of four cases. Ann Oncol. 2000; 11:1191–1194.
10. Lozano P, Gomez FT, Julia J, M-Rimbau E, Garcia F. Recurrent embolism caused by floating thrombus in the thoracic aorta. Ann Vasc Surg. 1998; 12:609–611.
Full Text Links
  • JKSR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr